Cargando…
Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease
BACKGROUND: It is well-established that influenza vaccination reduces adverse cardiovascular outcomes in patients with cardiovascular diseases (CVD), however, the vaccine coverage rate in most countries remains low. The concern about the local adverse effects of intramuscular injection, particularly...
Autores principales: | Phrommintikul, Arintaya, Wongcharoen, Wanwarang, Kuanprasert, Srun, Prasertwitayakij, Narawudt, Kanjanavanit, Rungsrit, Gunaparn, Siriluck, Sukonthasarn, Apichard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076453/ https://www.ncbi.nlm.nih.gov/pubmed/25009563 http://dx.doi.org/10.3969/j.issn.1671-5411.2014.02.007 |
Ejemplares similares
-
Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry
por: Wongcharoen, Wanwarang, et al.
Publicado: (2023) -
Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
por: Singkham, Noppaket, et al.
Publicado: (2022) -
Prevalence of atrial fibrillation in Thai elderly
por: Phrommintikul, Arintaya, et al.
Publicado: (2016) -
The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial
por: Sribhutorn, Apirak, et al.
Publicado: (2016) -
Influenza vaccination in acute coronary syndromes patients in Thailand: the cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia
por: Sribhutorn, Apirak, et al.
Publicado: (2018)